Ana Koren

Title: Ana Koren: Innovator in Allergy Therapy

Introduction

Ana Koren is a prominent inventor based in Ljubljana, Slovenia. She has made significant contributions to the field of allergy therapy through her innovative research and inventions. Her work focuses on developing solutions to combat allergic reactions, which affect millions of people worldwide.

Latest Patents

Ana Koren holds a patent for "IgE epitope-like peptides and uses thereof." This invention relates to IgE epitope-like peptides that have the ability to bind to allergen-specific IgE paratopes. These allergen-specific IgEs are bound to effector cells of allergic patients. The IgE epitope-like peptides cover the paratopes of the IgE bound on effector cells, preventing the binding of the causative allergen. This mechanism helps to prevent degranulation and the secretion of mediators of allergic inflammation from effector cells upon contact with the allergen. The invention also outlines methods for using these peptides in the therapy of allergic reactions caused by exposure to allergens.

Career Highlights

Throughout her career, Ana Koren has worked with esteemed institutions such as the University of Ljubljana and the University Clinic of Respiratory and Allergic Diseases. Her research has been pivotal in advancing the understanding and treatment of allergies.

Collaborations

Ana has collaborated with notable colleagues, including Mojca Lunder and Borut Štrukelj, contributing to a rich exchange of ideas and expertise in her field.

Conclusion

Ana Koren's innovative work in allergy therapy exemplifies the impact of scientific research on improving health outcomes. Her patent on IgE epitope-like peptides represents a significant advancement in the treatment of allergic reactions.